Juvenile Nasopharyngeal Angiofibroma: Combined Approach for Excision, Transpalatal and Endoscopic; A New Perspective.

Indian J Otolaryngol Head Neck Surg

Department of ENT Head and Neck Surgery, King George Medical University, Lucknow, 226003 India.

Published: March 2018

AI Article Synopsis

  • Juvenile angiofibroma is a rare, benign tumor mainly affecting young males, noted for its high vascularity and local invasiveness.
  • A study of 50 patients (ages 8-26) treated between 2011-2014 utilized a combined endoscopic and transpalatal surgical approach, with a mean operation time of 90 minutes and manageable bleeding.
  • Post-surgery, only 8% faced tumor recurrence and 10% experienced palatal perforation, indicating the effectiveness of this procedure for early to intermediate cases.

Article Abstract

Juvenile angiofibroma is a rare, highly vascular, histologically benign but locally invasive tumour, affecting predominantly male adolescents. To describe our experience in diagnosis of angiofibroma and treatment by combined endoscopic and transpalatal route. We analysed a case series of 50 patients of nasopharyngeal angiofibroma in Fisch stages I and II who presented at our institute during a period of four years 2011-2014, their clinical presentation, their treatment by combined transpalatal and endoscopic approach, intraoperative and post operative course, complications and tumour recurrence. Patients were aged 8-26 years. All patients were treated surgically by combined approach endoscopic and transpalatal. The mean operation time was 90 min, and the mean bleeding volume was 300 ml. Only 8 % patients came with recurrence and only 10 % came with palatal perforation (fistula formation). With gratifying results we advocate this novel technique for the treatment of early to intermediate JNA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807276PMC
http://dx.doi.org/10.1007/s12070-016-1027-8DOI Listing

Publication Analysis

Top Keywords

nasopharyngeal angiofibroma
8
combined approach
8
transpalatal endoscopic
8
treatment combined
8
endoscopic transpalatal
8
juvenile nasopharyngeal
4
angiofibroma
4
combined
4
angiofibroma combined
4
approach excision
4

Similar Publications

Alveolar rhabdomyosarcoma (aRMS) is a rare pediatric malignant tumor with a poor prognosis, particularly when located in the rhinopharynx and sphenoidal floor, which complicates diagnosis and increases the risk of misclassification as benign growths. The specific genotype of aRMS is associated with a worse clinical outcome. In young children, especially those aged 4 to 12 years, rhinopharyngeal masses are often attributed to chronic adenoiditis; however, other benign (e.

View Article and Find Full Text PDF

Objective: The objective of this study was to discuss the characteristics of intracranial extension in patients with juvenile nasopharyngeal angiofibroma (JNA) and propose and an algorithm for its management.

Methods: A retrospective chart review of all patients with JNA who underwent operations between January 2013 and January 2023 was done, and those cases with intracranial extension categorized as stage IIIb, IVa, and IVb according to the Andrews modification of the Fisch staging classification were included in the study. Data were collected about age at presentation, symptoms, radiological findings, routes of intracranial extension, therapeutic management, and follow-up.

View Article and Find Full Text PDF

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, locally aggressive, highly vascularized benign tumor classically found in males from 13 to 20 years old. The most common clinical presentations are recurrent epistaxis and nasal congestion. Imaging plays a significant role in differentiating and determining the extension of nasopharyngeal lesions.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes 12 cases of juvenile nasopharyngeal angiofibroma (JNA) in young males treated at a hospital between 2015 and 2020, focusing on the effectiveness of endoscopic plasma resection.
  • Preoperative imaging and selective artery embolization were performed, and patients were followed for at least 30 months to monitor outcomes.
  • Results showed clear vision, minimal bleeding, quick recovery, and no tumor recurrence, suggesting that this technique is a safe and effective treatment for JNA.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!